Heart to Heart International (HHI), a global humanitarian organization focused on improving access to health, announced a partnership with Intouch Group, an EVERSANA Company, to support improvements to community health clinics in both Kansas City and Chicago.
The European Commission wants to make health data easier to access by 2025 for patients, medics, regulators and researchers in a bid to improve diagnoses, cut unnecessary costs from duplication of medical tests and boost medicine research.
Roche sees slowdown in COVID-driven sales growthBusiness, Business Intelligence, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), Covid-19 antigen tests, COVID-19 Test Kits, COVID-19 Testing, Diagnostics, Earnings per share (EPS), Financials, Forecasts, Portable PCR COVID-19 Test Kits, Roche, Test Kits, Therapeutics
Roche’s first-quarter 2022 sales rose 10 percent on strong U.S. demand for rapid COVID-19 antigen tests and specialty drugs but the Swiss drugmaker reaffirmed that a drop in pandemic-related demand would put the brakes on growth.
Pharmaceutical companies launch the Precision Cancer Consortium to drive global access to comprehensive genomic testing for all patients with cancerBayer, Biotechnology Companies, Biotechnology Companies, Diagnostic Tools, Diagnostics, Genomic Tests, GlaxoSmithKline, Novartis, Oncology, Pharma Companies, Precision Oncology, Roche, Therapeutics
The Precision Cancer Consortium (PCC) announced its formation as a new collaboration of pharmaceutical companies with a shared vision of enabling access to comprehensive testing for all cancer patients globally.
Roche bolstered the Swiss pharma giant’s diagnostics capabilities by acquiring the company’s long-term partner, TIB Molbiol. The procurement will expand Roche’s PCR-test portfolio capabilities in the ongoing fight against existing and emerging infectious diseases, including new Covid-19 variants of interest.
BioSpace takes a look at the flurry of expansion activity in the life sciences industry as biopharma and diagnostic companies expand manufacturing sites.
Swiss drugmaker Roche predicted on April 21 that demand for the company’s drugs would accelerate for the remainder of 2021, after first-quarter sales of Covid-19 tests offset a pandemic-influenced slump in its main pharmaceuticals business.
For the second year in a row, California-based Agilent Technologies – a leader in diagnostics and applied chemical markets – was ranked as one of Barron’s most sustainable companies.
FDA Awards Fast Track Designation to Multiple Non-Covid-19 CandidatesAcid Disorders, Acute repetitive seizures, Coronavirus Disease (COVID-19) Pandemic, Fast Track Designation, FDA, Gene Therapy, Hypogammaglobulinemia, Imaging Agents, Infections and Myelokathexis) syndrome, Methylmalonic Acidemia (MMA), MPS Type VI, Non-Small Cell Lung Cancer (NSCLC), Phenylketonuria (PKU), Primary Mitochondrial Myopathy (PMM), Solid Tumors, WHIM (Warts
While the world has largely been focused on the development of vaccines and therapeutics for Covid-19, the U.S. Food and Drug Administration has remained busy lining up potential approvals of medications for other diseases and illnesses.
White Paper: Consistent Terms for Testing in Precision MedicineAmerican Society of Clinical Oncology (ASCO), Biomarkers, Biotech, Cancer, Diagnostics, Genetic Testing, Hematologic malignancies, Inherited Mutations, Medical Societies, Patient Advocates, Patient Education, Pharma, Precision Medicine, Solid Tumors, Testing Labs, White Papers
The Consistent Testing Terminology Working Group published a white paper with industry-wide recommendations for precision medicine testing terms to be utilized in patient education and communication.